Sunday, January 19, 2014 12:30:04 PM
Recent ANGO News
- AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions • Business Wire • 05/06/2024 08:45:00 PM
- US Index Futures Rise, Oil Dips Slightly • IH Market News • 04/04/2024 11:31:45 AM
- AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture • Business Wire • 04/04/2024 11:00:00 AM
- AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE • Business Wire • 04/04/2024 10:45:00 AM
- AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc. • Business Wire • 04/01/2024 09:26:00 PM
- AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024 • Business Wire • 03/19/2024 08:01:00 PM
- AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference • Business Wire • 03/06/2024 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 01:49:30 AM
- AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million • Business Wire • 02/15/2024 09:05:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/23/2024 09:14:00 PM
- AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease • Business Wire • 01/23/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 12:30:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 12:30:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/08/2024 09:47:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 12:15:29 PM
- AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance • Business Wire • 01/05/2024 12:00:00 PM
- AngioDynamics to Present at the J.P. Morgan Healthcare Conference • Business Wire • 12/21/2023 09:01:00 PM
- AngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024 • Business Wire • 12/07/2023 09:01:00 PM
- AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism • Business Wire • 12/07/2023 01:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/07/2023 01:03:44 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/05/2023 09:15:12 PM
- Wednesday’s Wall Street Highlights: Apple, Intel, Cal-Maine, A10 Networks, and more • IH Market News • 10/04/2023 11:22:09 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 11:15:31 AM
- AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance • Business Wire • 10/04/2023 11:00:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM